Use of Ocudox™ or hypochlorous acid to inactivate SARS-CoV-2 as an alternative to alcohol-based products

Main Article Content

Cristina Lorca-Oró
Núria Roca
Carmen Gomez Martín
Xavier Abad


Objective: The main route of entry of SARS-CoV-2 which responsible of COVID-19 is through the nasal, oral, or conjunctival mucosa and droplets or aerosols transmit the virus. Even if transmission through fomites is considered unlikely, hand hygiene is important to minimize this and other infections, especially in certain scenarios as healthcare facilities and crowded places as public transport or social events. 

Material and methods: In this study, we assess and compare the virucidal efficacy of HOCl solutions against SARS-CoV-2 at different time-points. a nasopharyngeal swab collected from an 89-year-old male patient during March 2020 in Catalonia, Spain (GISEAD ID EPI_ISL_510689). The virus was propagated in Vero E6 cells (ATCC CRL-1586) cultured in Dulbecco’s modified Eagle medium (DMEM). A total of 24 plastic plates (35 mm SPL Ref. PLC20035) for the first study, and 12 plates for the second one, were prepared. One day before titration, 96-well plates were prepared with Vero E6 cells. The day of titration, two replicates of five 10-fold serial dilutions of each sample were performed. Plates were incubated at 37°C and 5% CO2 for 7 days, and afterward, SARS-CoV-2-induced cytopathic effect (CPE) was determined under light microscope

Results: The virucidal effect by means of TCID50/mL found after HOCl treatment at different concentrations and times tested. Logarithmic reduction (logR) and the correspondent percentage of inactivation (%) were calculated compared to the untreated controls (desiccated SARS-CoV-2 with water or media). All tested concentrations were able to partially inhibit SARS-CoV-2

Conclusion: Our studies showed that HOCl products represent a valid virucidal alternative to inactivate SARS-CoV-2 potentially present in skin or surfaces.


Download data is not yet available.

Article Details

How to Cite
Lorca-Oró, C. ., Roca, N. ., Martín, C. G., & Abad, X. . (2022). Use of Ocudox™ or hypochlorous acid to inactivate SARS-CoV-2 as an alternative to alcohol-based products. Medical Science and Discovery, 9(11), 636–638.
Research Article
Received 2022-11-14
Accepted 2022-11-24
Published 2022-11-29


Berardi A, Perinelli DR, Merchant HA, Bisharat L, Basheti IA, Bonacucina G, Cespi M, Palmieri GF. Hand sanitisers amid CoViD-19: A critical review of alcohol-based products on the market and formulation approaches to respond to increasing demand. International journal of pharmaceutics. 2020 Jun 30;584:119431.

Schalock PC, Dunnick CA, Nedorost S, Brod B, Warshaw E, Mowad C. American Contact Dermatitis Society core allergen series: 2017 update. Dermatitis®. 2017 Mar 1;28(2):141-3.

Block MS, Rowan BG. Hypochlorous acid: a review. Journal of Oral and Maxillofacial Surgery. 2020 Sep 1;78(9):1461-6. (4)

US Environmental Protection Agengy List N: Disinfectants for use against SARS-Cov-2 (Online). (cited 2021 January 19. Available from:

Lewis D. COVID-19 rarely spreads through surfaces. So why are we still deep cleaning. Nature. 2021 Feb 4;590(7844):26-8.

Hirose R, Itoh Y, Ikegaya H, Miyazaki H, Watanabe N, Yoshida T, Bandou R, Daidoji T, Nakaya T. Differences in environmental stability among SARS-CoV-2 variants of concern: Omicron has higher stability. bioRxiv. 2022 Jan 1.